EFFERALGANMED PEDIATRIQUE (paracetamol) - Mild to moderate pain and/or fever
Opinions on drugs -
Posted on
May 06 2024
Reason for request
Modification of the listing conditions
Summary of opinion
Favourable opinion for maintenance of reimbursement in “the symptomatic treatment of mild to moderate pain and/or fever. This form is RESERVED FOR CHILDREN weighing from 3 to 32 kg (from birth to around 12 years)”.
Clinical Benefit
Substantial |
The Committee considers that the clinical benefit of EFFERALGANMED 30 mg/ml oral solution is substantial in the MA indication. |
Clinical Added Value
Not applicable |
English version
Contact Us
Évaluation des médicaments